C
Market Data
$4.00+$0.37 (+10.19%)
CTMX · Last trade
Prev Close
$3.63
Range (29d)
$3.77 – $4.29
Recent Filings
- SC 13G/A283.4 KBCytomX Therapeutics, Inc.Nov 14, 4:26 PM ET·0000921895-24-002717
- SC 13G/A136.5 KBCytomX Therapeutics, Inc.Nov 14, 4:00 PM ET·0001214659-24-019106
- SC 13G/A87.7 KBCytomX Therapeutics, Inc.Nov 14, 3:03 PM ET·0001172661-24-005044
- SC 13G/A13.1 KBCytomX Therapeutics, Inc.Nov 14, 12:28 PM ET·0001274173-24-000114
- 8-K413.8 KBCytomX Therapeutics, Inc.Nov 7, 4:09 PM ET·0000950170-24-123314
- 10-Q8.2 MBCytomX Therapeutics, Inc.Nov 7, 4:02 PM ET·0000950170-24-123249
- 8-K417.6 KBCytomX Therapeutics, Inc.Aug 8, 4:08 PM ET·0000950170-24-093936
- 10-Q7.9 MBCytomX Therapeutics, Inc.Aug 8, 4:03 PM ET·0000950170-24-093865
- 8-K150.2 KBCytomX Therapeutics, Inc.Jun 17, 4:35 PM ET·0001193125-24-162652
- SC 13G13.0 KBCytomX Therapeutics, Inc.May 22, 4:06 PM ET·0001274173-24-000069
Insiders
10- Ashworth AlanDirector
- BELVIN MARCIASVP, Chief Scientific Officer
- Campoy CarlosChief Financial Officer
- Canaan Partners IX LLCDirector, 10% Owner
- Chu Yu-WayeChief Medical Officer
- Gilbert Halley EDirector
- GLUCK FREDERICK WDirector
- Goeltz II Robert C.Chief Financial Officer
- HUMPHREY RACHELChief Medical Officer
- Jones Elaine VDirector
Tickers
Addresses
business
151 OYSTER POINT BLVD. SUITE 400
SOUTH SAN FRANCISCO, CA, 94080
mailing
151 OYSTER POINT BLVD. SUITE 400
SOUTH SAN FRANCISCO, CA, 94080